{
  "symbol": "NVAX",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biotechnology sector", "COVID-19 vaccine development", "small-cap stock"],
    "riskScore": 7,
    "reason": "Novavax operates in the biotechnology sector, focusing on vaccine development, including COVID-19, which is prone to social media hype and retail speculation. Its small-cap status further increases susceptibility to volatility."
  }
}